Therapeutic approaches to COVID-19 treatment require appropriate inhibitors to target
crucial proteins of SARS-CoV-2 replication machinery. It's been approximately 12 months …

Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and …

COVID-19, an extremely transmissible and pathogenic viral disease, triggered a global
pandemic that claimed lives worldwide. To date, there is no clear and fully effective …

When SARS-CoV-2 emerged at the end of 2019, no approved therapeutics or vaccines were
available. An urgent need for countermeasures during this crisis challenges the current …

There is a large global unmet need for effective countermeasures to combat severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus …

The SARS-CoV-2 pandemic, declared as a global health emergency by the WHO in
February 2020, has currently infected more than 6 million people with fatalities near 371,000 …

The emergence of SARS-CoV-2 triggering the COVID-19 pandemic ranks as arguably the
greatest medical emergency of the last century. COVID-19 has highlighted health disparities …

While the COVID-19 pandemic has spurred intense research and collaborative discovery
worldwide, the development of a safe, effective, and targeted antiviral from the ground up is …

The coronavirus disease 2019 (COVID-19) pandemic has claimed over 7 million lives
worldwide, providing a stark reminder of the importance of pandemic preparedness. Due to …

After emerging in China in late 2019, the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …